185 related articles for article (PubMed ID: 20632394)
41. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
N Engl J Med; 2006 Sep; 355(12):1210-21. PubMed ID: 16990384
[TBL] [Abstract][Full Text] [Related]
42. Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study).
de la Fuente LM; Stertzer SH; Argentieri J; Peñaloza E; Koziner B; Rouy D; Altman PA
EuroIntervention; 2011 Nov; 7(7):805-12. PubMed ID: 22082576
[TBL] [Abstract][Full Text] [Related]
43. Autologous bone marrow-derived progenitor cell myocardial delivery for recent myocardial infarction patients following early angioplasty: results from a pilot study.
Jyotsna M; Vemuganti GK; Reddy P; Chandra KS
Cardiovasc Revasc Med; 2006; 7(4):217-21. PubMed ID: 17174867
[TBL] [Abstract][Full Text] [Related]
44. Encouraging experience with intracardiac transplantation of unselected autologous bone marrow cells concomitant with coronary artery bypass surgery after myocardial infarction.
Holinski S; Schmeck B; Claus B; Radtke H; Elgeti T; Holzhausen M; Konertz W
Ann Thorac Cardiovasc Surg; 2011; 17(4):383-9. PubMed ID: 21881326
[TBL] [Abstract][Full Text] [Related]
45. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
46. Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).
Brenner C; Adrion C; Grabmaier U; Theisen D; von Ziegler F; Leber A; Becker A; Sohn HY; Hoffmann E; Mansmann U; Steinbeck G; Franz WM; Theiss HD
Int J Cardiol; 2016 Feb; 205():23-30. PubMed ID: 26709136
[TBL] [Abstract][Full Text] [Related]
47. Granulocyte colony stimulating factor, peripheral blood stem cells and bone marrow stem cells for cardiac repair after myocardial infarction.
Minatoguchi S
Circ J; 2011; 75(4):789-90. PubMed ID: 21372406
[No Abstract] [Full Text] [Related]
48. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.
Steinwender C; Hofmann R; Kammler J; Kypta A; Pichler R; Maschek W; Schuster G; Gabriel C; Leisch F
Am Heart J; 2006 Jun; 151(6):1296.e7-13. PubMed ID: 16781240
[TBL] [Abstract][Full Text] [Related]
49. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
[TBL] [Abstract][Full Text] [Related]
50. Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy.
Rupp S; Bauer J; Tonn T; Schächinger V; Dimmeler S; Zeiher AM; Schranz D
Pediatr Transplant; 2009 Aug; 13(5):620-3. PubMed ID: 19067928
[TBL] [Abstract][Full Text] [Related]
51. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
[TBL] [Abstract][Full Text] [Related]
52. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
[TBL] [Abstract][Full Text] [Related]
53. Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.
Zhang Y; Sievers RE; Prasad M; Mirsky R; Shih H; Wong ML; Angeli FS; Ye J; Takagawa J; Koskenvuo JW; Springer ML; Grossman W; Boyle AJ; Yeghiazarians Y
Cardiovasc Pathol; 2011; 20(4):204-12. PubMed ID: 20667749
[TBL] [Abstract][Full Text] [Related]
54. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
[TBL] [Abstract][Full Text] [Related]
55. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial.
Andreone P; Catani L; Margini C; Brodosi L; Lorenzini S; Sollazzo D; Nicolini B; Giordano R; Montemurro T; Rizzi S; Dan E; Giudice V; Viganò M; Casadei A; Foschi FG; Malvi D; Bernardi M; Conti F; Lemoli RM
Dig Liver Dis; 2015 Dec; 47(12):1059-66. PubMed ID: 26427587
[TBL] [Abstract][Full Text] [Related]
56. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease.
Mozid AM; Jones D; Arnous S; Saunders N; Wragg A; Martin J; Agrawal S; Mathur A
Stem Cells Dev; 2013 Jan; 22(2):216-23. PubMed ID: 22834565
[TBL] [Abstract][Full Text] [Related]
57. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
58. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
[TBL] [Abstract][Full Text] [Related]
59. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
[TBL] [Abstract][Full Text] [Related]
60. Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133
Steinhoff G; Nesteruk J; Wolfien M; Kundt G; ; Börgermann J; David R; Garbade J; Große J; Haverich A; Hennig H; Kaminski A; Lotz J; Mohr FW; Müller P; Oostendorp R; Ruch U; Sarikouch S; Skorska A; Stamm C; Tiedemann G; Wagner FM; Wolkenhauer O
EBioMedicine; 2017 Aug; 22():208-224. PubMed ID: 28781130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
